Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	123	113	81	74	68	46	Upgrade
Market Cap Growth	64.04%	38.87%	9.12%	8.62%	50.10%	-26.04%	Upgrade
Last Close Price	20.70	19.20	14.17	13.47	12.78	8.62	Upgrade
PE Ratio	16.02	12.73	6.89	8.79	8.83	11.57	Upgrade
PS Ratio	3.50	3.10	1.98	2.19	2.27	2.08	Upgrade
Earnings Yield	6.32%	7.85%	14.52%	11.37%	11.33%	8.64%	Upgrade
Buyback Yield / Dilution	-3.57%	-4.40%	-2.25%	-1.90%	-2.48%	-1.46%	Upgrade

Source: S&P Global Market Intelligence. Banks template. Financial Sources.